trial
as of 2026-07-01Tetrabenazine for Partial Responders
NCTId NCT00362804
at a glance
— · Completed
Enrollment 41 (actual)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2006-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
41 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2002-02
Primary completion
2006-01
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
Stanley Medical Research InstituteCollaborator
Investigators
1
Gary Remington, MD PhD FRCPCPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
41
Phase
NA
Primary Completion Date
2006-01
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator